• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Health state utilities for skeletal-related events secondary to bone metastases.骨转移继发骨相关事件的健康状态效用值。
Eur J Health Econ. 2014 Jan;15(1):7-18. doi: 10.1007/s10198-012-0443-2. Epub 2013 Jan 25.
2
Pharmacoeconomics of bisphosphonates for skeletal-related event prevention in metastatic non-breast solid tumours.双膦酸盐类药物在预防转移性非乳腺癌实体瘤骨骼相关事件中的药物经济学评价。
Pharmacoeconomics. 2012 May;30(5):373-86. doi: 10.2165/11631390-000000000-00000.
3
The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer.肺癌骨转移患者骨相关事件的治疗费用。
Oncology. 2004;67(5-6):390-6. doi: 10.1159/000082923.
4
The economic burden associated with skeletal-related events in patients with bone metastases secondary to solid tumors in Belgium.比利时因实体瘤骨转移导致骨骼相关事件的患者的经济负担。
J Med Econ. 2013;16(4):539-46. doi: 10.3111/13696998.2013.774279. Epub 2013 Feb 21.
5
Health state utilities associated with attributes of treatments for hepatitis C.与丙型肝炎治疗属性相关的健康状态效用值。
Eur J Health Econ. 2015 Dec;16(9):1005-18. doi: 10.1007/s10198-014-0649-6. Epub 2014 Dec 7.
6
Utilities associated with subcutaneous injections and intravenous infusions for treatment of patients with bone metastases.与皮下注射和静脉输注相关的用于治疗骨转移患者的实用方法。
Patient Prefer Adherence. 2013 Aug 29;7:855-65. doi: 10.2147/PPA.S44947. eCollection 2013.
7
Healthcare costs associated with skeletal-related events in breast cancer patients with bone metastases.与乳腺癌伴骨转移患者骨骼相关事件相关的医疗保健费用。
J Med Econ. 2014 Mar;17(3):223-30. doi: 10.3111/13696998.2014.890937.
8
Estimating health state utilities associated with a rare disease: familial chylomicronemia syndrome (FCS).评估与罕见疾病相关的健康状态效用值:家族性乳糜微粒血症综合征(FCS)。
J Med Econ. 2020 Sep;23(9):978-984. doi: 10.1080/13696998.2020.1776719. Epub 2020 Jul 1.
9
Bone metastases and skeletal-related events in patients with malignant pheochromocytoma and sympathetic paraganglioma.恶性嗜铬细胞瘤和副神经节瘤患者的骨转移和骨骼相关事件。
J Clin Endocrinol Metab. 2013 Apr;98(4):1492-7. doi: 10.1210/jc.2012-4231. Epub 2013 Feb 22.
10
Cost effectiveness of bisphosphonates in the management of breast cancer patients with bone metastases.双膦酸盐类药物在治疗乳腺癌骨转移患者中的成本效益
Ann Oncol. 2006 Jul;17(7):1072-82. doi: 10.1093/annonc/mdl093. Epub 2006 May 2.

引用本文的文献

1
Health state utilities associated with invasive pneumococcal disease, pneumonia, and recurrent acute otitis media in young children.幼儿侵袭性肺炎球菌疾病、肺炎和复发性急性中耳炎相关的健康状态效用值。
Qual Life Res. 2025 Mar;34(3):809-821. doi: 10.1007/s11136-024-03840-8. Epub 2025 Jan 3.
2
Cost-Effectiveness Analysis of Denosumab in the Prevention of Skeletal-Related Events Among Patients With Breast Cancer With Bone Metastasis in India.印度乳腺癌伴骨转移患者使用地舒单抗预防骨骼相关事件的成本效果分析。
JCO Glob Oncol. 2024 Mar;10:e2300396. doi: 10.1200/GO.23.00396.
3
Early economic modeling of magnetic resonance image-guided high intensity focused ultrasound compared to radiotherapy for pain palliation of bone metastases.与放射治疗相比,磁共振成像引导下的高强度聚焦超声用于骨转移瘤疼痛缓解的早期经济学模型分析
Front Oncol. 2022 Sep 23;12:987546. doi: 10.3389/fonc.2022.987546. eCollection 2022.
4
A cost-utility analysis of apalutamide for metastatic castrationsensitive prostate cancer.阿帕鲁胺用于转移性去势敏感性前列腺癌的成本效用分析。
Can Urol Assoc J. 2022 Mar;16(3):E126-E131. doi: 10.5489/cuaj.7495.
5
Health state utility values by cancer stage: a systematic literature review.癌症分期的健康状态效用值:系统文献回顾。
Eur J Health Econ. 2021 Nov;22(8):1275-1288. doi: 10.1007/s10198-021-01335-8. Epub 2021 Jun 14.
6
End-of-Range Radiobiological Effect on Rib Fractures in Patients Receiving Proton Therapy for Breast Cancer.端区放射生物学效应对乳腺癌质子治疗患者肋骨骨折的影响。
Int J Radiat Oncol Biol Phys. 2020 Jul 1;107(3):449-454. doi: 10.1016/j.ijrobp.2020.03.012. Epub 2020 Mar 30.
7
Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients.系统评价转移性非小细胞肺癌的健康状态效用值,重点关注既往治疗患者。
Health Qual Life Outcomes. 2018 Sep 12;16(1):179. doi: 10.1186/s12955-018-0994-8.
8
Risks associated with antiretroviral treatment for human immunodeficiency virus (HIV): qualitative analysis of social media data and health state utility valuation.人类免疫缺陷病毒(HIV)抗逆转录病毒治疗相关风险:社交媒体数据的定性分析与健康状态效用评估
Qual Life Res. 2017 Jul;26(7):1785-1798. doi: 10.1007/s11136-017-1519-3. Epub 2017 Mar 24.
9
Health-related Quality of Life in Patients with Metastatic Spinal Cord Compression.转移性脊髓压迫症患者的健康相关生活质量
Orthop Surg. 2016 Aug;8(3):309-15. doi: 10.1111/os.12253.
10
Prognostic Value of Chemotherapy-Induced Neutropenia at the First Cycle in Invasive Breast Cancer.侵袭性乳腺癌首个周期化疗引起的中性粒细胞减少的预后价值
Medicine (Baltimore). 2016 Mar;95(13):e3240. doi: 10.1097/MD.0000000000003240.

本文引用的文献

1
Using QALYs in cancer: a review of the methodological limitations.使用 QALYs 评估癌症:方法学局限性的综述。
Pharmacoeconomics. 2011 Aug;29(8):673-85. doi: 10.2165/11588250-000000000-00000.
2
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study.地舒单抗对比唑来膦酸治疗去势抵抗性前列腺癌骨转移患者的随机、双盲研究。
Lancet. 2011 Mar 5;377(9768):813-22. doi: 10.1016/S0140-6736(10)62344-6. Epub 2011 Feb 25.
3
Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study.地舒单抗对比唑来膦酸治疗晚期乳腺癌骨转移患者的随机、双盲研究。
J Clin Oncol. 2010 Dec 10;28(35):5132-9. doi: 10.1200/JCO.2010.29.7101. Epub 2010 Nov 8.
4
Utilities and disutilities for attributes of injectable treatments for type 2 diabetes.用于 2 型糖尿病注射治疗属性的效用和非效用。
Eur J Health Econ. 2011 Jun;12(3):219-30. doi: 10.1007/s10198-010-0224-8. Epub 2010 Mar 12.
5
Health utility estimation.健康效用值评估。
Expert Rev Pharmacoecon Outcomes Res. 2002 Apr;2(2):99-108. doi: 10.1586/14737167.2.2.99.
6
The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22.欧洲癌症研究与治疗组织骨转移患者生活质量问卷:EORTC QLQ-BM22
Eur J Cancer. 2009 May;45(7):1146-1152. doi: 10.1016/j.ejca.2008.11.013. Epub 2008 Dec 25.
7
Valuing health States for use in cost-effectiveness analysis.评估用于成本效益分析的健康状态。
Pharmacoeconomics. 2008;26(9):769-79. doi: 10.2165/00019053-200826090-00007.
8
How consistent are health utility values?
Qual Life Res. 2008 Sep;17(7):1031-42. doi: 10.1007/s11136-008-9368-8. Epub 2008 Aug 8.
9
Utilities and disutilities for type 2 diabetes treatment-related attributes.2型糖尿病治疗相关属性的效用和负效用。
Qual Life Res. 2007 Sep;16(7):1251-65. doi: 10.1007/s11136-007-9226-0. Epub 2007 Jul 19.
10
Tumor metastasis to bone.肿瘤骨转移。
Arthritis Res Ther. 2007;9 Suppl 1(Suppl 1):S5. doi: 10.1186/ar2169.

骨转移继发骨相关事件的健康状态效用值。

Health state utilities for skeletal-related events secondary to bone metastases.

作者信息

Matza Louis S, Chung Karen, Van Brunt Kate, Brazier John E, Braun Ada, Currie Brooke, Palsgrove Andrew, Davies Evan, Body Jean-Jacques

机构信息

Outcomes Research, United BioSource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD, 20814, USA,

出版信息

Eur J Health Econ. 2014 Jan;15(1):7-18. doi: 10.1007/s10198-012-0443-2. Epub 2013 Jan 25.

DOI:10.1007/s10198-012-0443-2
PMID:23355121
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3889679/
Abstract

INTRODUCTION

Patients with bone metastases often experience skeletal-related events (SREs). Although cost-utility models are used to examine treatments for metastatic cancer, limited information is available on utilities of SREs. The purpose of this study was to estimate the disutility of four SREs: spinal cord compression, pathological fracture, radiation to bone, and surgery performed to stabilize a bone.

METHODS

General population participants from the UK and Canada completed time trade-off (TTO) interviews to assess the utility of health states drafted based on literature review, clinician interviews, and patient interviews. Respondents first rated a health state describing cancer with bone metastases. Then, the SREs were added to this health state.

RESULTS

Interviews were completed with 187 participants (50.8 % male, 80.2 % white). Cancer with bone metastases without an SRE had a mean utility of 0.47 (SD = 0.43) on a standard utility scale (1 = full health, 0 = death). Of the SREs, spinal cord compression was associated with the greatest disutility (i.e., the utility decrease): -0.32 with paralysis and -0.22 without paralysis. Surgery had a disutility of -0.07. Leg, arm, and rib fractures had disutilities of -0.06, -0.04, and -0.03. Two weeks of daily radiation treatment had a disutility of -0.06, while two radiation appointments had the smallest impact on utility (-0.02).

CONCLUSION

All SREs were associated with statistically significant utility decreases, suggesting a perceived impact on quality of life beyond the impact of cancer with bone metastases. The resulting disutilities may be used in cost-utility models examining treatments to prevent SREs secondary to bone metastases.

摘要

引言

骨转移患者常经历骨相关事件(SREs)。尽管成本效用模型用于研究转移性癌症的治疗方法,但关于SREs效用的信息有限。本研究的目的是评估四种SREs的负效用:脊髓压迫、病理性骨折、骨放疗以及为稳定骨骼而进行的手术。

方法

来自英国和加拿大的普通人群参与者完成了时间权衡(TTO)访谈,以评估基于文献综述、临床医生访谈和患者访谈起草的健康状态的效用。受访者首先对描述伴有骨转移的癌症的健康状态进行评分。然后,将SREs添加到该健康状态中。

结果

对187名参与者进行了访谈(男性占50.8%,白人占80.2%)。在标准效用量表(1 = 完全健康,0 = 死亡)上,无SREs的伴有骨转移的癌症的平均效用为0.47(标准差 = 0.43)。在SREs中,脊髓压迫与最大的负效用相关(即效用降低):瘫痪时为 -0.32,无瘫痪时为 -0.22。手术的负效用为 -0.07。腿部、手臂和肋骨骨折的负效用分别为 -0.06、-0.04和 -0.03。两周的每日放疗负效用为 -0.06,而两次放疗预约对效用的影响最小(-0.02)。

结论

所有SREs均与统计学上显著的效用降低相关,表明其对生活质量的影响被认为超过了伴有骨转移的癌症的影响。由此产生的负效用可用于成本效用模型,以研究预防骨转移继发SREs的治疗方法。